These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 9581716)

  • 1. Normal triglyceride levels and coronary artery disease events: the Baltimore Coronary Observational Long-Term Study.
    Miller M; Seidler A; Moalemi A; Pearson TA
    J Am Coll Cardiol; 1998 May; 31(6):1252-7. PubMed ID: 9581716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study.
    Downs JR; Clearfield M; Weis S; Whitney E; Shapiro DR; Beere PA; Langendorfer A; Stein EA; Kruyer W; Gotto AM
    JAMA; 1998 May; 279(20):1615-22. PubMed ID: 9613910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term predictors of subsequent cardiovascular events with coronary artery disease and 'desirable' levels of plasma total cholesterol.
    Miller M; Seidler A; Kwiterovich PO; Pearson TA
    Circulation; 1992 Oct; 86(4):1165-70. PubMed ID: 1394924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Elevated Triglycerides With Increased Cardiovascular Risk and Direct Costs in Statin-Treated Patients.
    Toth PP; Philip S; Hull M; Granowitz C
    Mayo Clin Proc; 2019 Sep; 94(9):1670-1680. PubMed ID: 31405751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of remnant-like lipoprotein particles in postmenopausal women with and without coronary artery disease and in men with coronary artery disease.
    Fukushima H; Kugiyama K; Sugiyama S; Honda O; Koide S; Nakamura S; Kawano H; Soejima H; Miyamoto S; Yoshimura M; Sakamoto T; Ogawa H
    Am J Cardiol; 2001 Dec; 88(12):1370-3. PubMed ID: 11741554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triglyceride to high-density lipoprotein cholesterol ratio as a predictor of long-term mortality in patients with coronary artery disease after undergoing percutaneous coronary intervention: a retrospective cohort study.
    Dai XY; Zheng YY; Tang JN; Yang XM; Guo QQ; Zhang JC; Cheng MD; Song FH; Liu ZY; Wang K; Jiang LZ; Fan L; Yue XT; Bai Y; Zhang ZL; Zheng RJ; Zhang JY
    Lipids Health Dis; 2019 Dec; 18(1):210. PubMed ID: 31801554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of atherogenic dyslipidemia for predicting cardiovascular risk in patients with angiographically defined coronary artery disease.
    Arca M; Montali A; Valiante S; Campagna F; Pigna G; Paoletti V; Antonini R; Barillà F; Tanzilli G; Vestri A; Gaudio C
    Am J Cardiol; 2007 Nov; 100(10):1511-6. PubMed ID: 17996510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma triglycerides and type III hyperlipidemia are independently associated with premature familial coronary artery disease.
    Hopkins PN; Wu LL; Hunt SC; Brinton EA
    J Am Coll Cardiol; 2005 Apr; 45(7):1003-12. PubMed ID: 15808755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for coronary artery disease in patients with elevated high-density lipoprotein cholesterol.
    DeFaria Yeh D; Freeman MW; Meigs JB; Grant RW
    Am J Cardiol; 2007 Jan; 99(1):1-4. PubMed ID: 17196452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive value of remnant lipoprotein for cardiovascular events in patients with coronary artery disease after achievement of LDL-cholesterol goals.
    Nakamura T; Obata JE; Hirano M; Kitta Y; Fujioka D; Saito Y; Kawabata K; Watanabe K; Watanabe Y; Mishina H; Kugiyama K
    Atherosclerosis; 2011 Sep; 218(1):163-7. PubMed ID: 21605862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-HDL Cholesterol and Triglycerides: Implications for Coronary Atheroma Progression and Clinical Events.
    Puri R; Nissen SE; Shao M; Elshazly MB; Kataoka Y; Kapadia SR; Tuzcu EM; Nicholls SJ
    Arterioscler Thromb Vasc Biol; 2016 Nov; 36(11):2220-2228. PubMed ID: 27515380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triglyceride to High-Density Lipoprotein Cholesterol Ratio and Cardiovascular Events in Diabetics With Coronary Artery Disease.
    Yang SH; Du Y; Li XL; Zhang Y; Li S; Xu RX; Zhu CG; Guo YL; Wu NQ; Qing P; Gao Y; Cui CJ; Dong Q; Sun J; Li JJ
    Am J Med Sci; 2017 Aug; 354(2):117-124. PubMed ID: 28864368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association Between Triglycerides and Residual Cardiovascular Risk in Patients With Type 2 Diabetes Mellitus and Established Cardiovascular Disease (From the Bypass Angioplasty Revascularization Investigation 2 Diabetes [BARI 2D] Trial).
    Nelson AJ; Navar AM; Mulder H; Wojdyla D; Philip S; Granowitz C; Peterson ED; Pagidipati NJ
    Am J Cardiol; 2020 Oct; 132():36-43. PubMed ID: 32773223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The beneficial effects of raising high-density lipoprotein cholesterol depends upon achieved levels of low-density lipoprotein cholesterol during statin therapy: Implications for coronary atheroma progression and cardiovascular events.
    Puri R; Nissen SE; Shao M; Kataoka Y; Uno K; Kapadia SR; Tuzcu EM; Nicholls SJ
    Eur J Prev Cardiol; 2016 Mar; 23(5):474-85. PubMed ID: 25691546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The association between triglyceride/high-density lipoprotein cholesterol ratio and all-cause mortality in acute coronary syndrome after coronary revascularization.
    Wan K; Zhao J; Huang H; Zhang Q; Chen X; Zeng Z; Zhang L; Chen Y
    PLoS One; 2015; 10(4):e0123521. PubMed ID: 25880982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma triglyceride level and mortality from coronary heart disease.
    Criqui MH; Heiss G; Cohn R; Cowan LD; Suchindran CM; Bangdiwala S; Kritchevsky S; Jacobs DR; O'Grady HK; Davis CE
    N Engl J Med; 1993 Apr; 328(17):1220-5. PubMed ID: 8464432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of coronary heart disease is associated with triglycerides and high-density lipoprotein cholesterol in women and non-high-density lipoprotein cholesterol in men.
    Abdel-Maksoud MF; Eckel RH; Hamman RF; Hokanson JE
    J Clin Lipidol; 2012; 6(4):374-81. PubMed ID: 22836075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relation of clinical benefit of raising high-density lipoprotein cholesterol to serum levels of low-density lipoprotein cholesterol in patients with coronary heart disease (from the Bezafibrate Infarction Prevention Trial).
    Goldenberg I; Benderly M; Sidi R; Boyko V; Tenenbaum A; Tanne D; Behar S
    Am J Cardiol; 2009 Jan; 103(1):41-5. PubMed ID: 19101227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Candidate gene susceptibility variants predict intermediate end points but not angiographic coronary artery disease.
    Whiting BM; Anderson JL; Muhlestein JB; Horne BD; Bair TL; Pearson RR; Carlquist JF;
    Am Heart J; 2005 Aug; 150(2):243-50. PubMed ID: 16086925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The independent correlation between high-density lipoprotein cholesterol and subsequent major adverse coronary events.
    Koro CE; Bowlin SJ; Stump TE; Sprecher DL; Tierney WM
    Am Heart J; 2006 Mar; 151(3):755.e1-755.e6. PubMed ID: 16504648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.